Ligand id: 8997

Name: ligelizumab

Compound class Antibody
International Nonproprietary Names
INN number INN
9653 ligelizumab
CL-2C | NVP-QGE031 | QGE031
Ligelizumab is a humanized, investigational high-affinity anti-IgE monoclonal antibody with anti-inflammatory potential [1], with improved pharmacokinetics and clinical effects compared to omalizumab.
Peptide sequences for this antibody are available from its IMGT/mAb-DB record.
BLAST peptide sequence analysis reveals identical matches with antibody sequences claimed in patent US7531169 B2, where it is the clone designated as CL-2C [3].
Database Links
Specialist databases
IMGT/mAb-DB 422
Other databases
GtoPdb PubChem SID 310264775
Search PubMed clinical trials ligelizumab
Search PubMed titles ligelizumab
Search PubMed titles/abstracts ligelizumab